- Report
- June 2022
- 53 Pages
Global
From €1919EUR$2,000USD£1,648GBP
- Drug Pipelines
- June 2020
- 65 Pages
Global
From €1919EUR$2,000USD£1,648GBP
- Report
- February 2024
- 211 Pages
China
From €3837EUR$4,000USD£3,296GBP
- Report
- April 2024
- 160 Pages
From €5755EUR$5,999USD£4,944GBP
The Peptic Ulcer Drug market is a subset of the Gastrointestinal Drugs market, which includes medications used to treat diseases and disorders of the digestive system. Peptic Ulcer Drugs are used to treat peptic ulcers, which are sores that form in the lining of the stomach or small intestine. These drugs work by reducing the amount of acid produced in the stomach, which helps to reduce pain and promote healing. Commonly used Peptic Ulcer Drugs include proton pump inhibitors, H2 blockers, and antacids.
The Peptic Ulcer Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, GlaxoSmithKline, AstraZeneca, Merck, and Novartis. Show Less Read more